A detailed history of Royal Bank Of Canada transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 4,684 shares of HRMY stock, worth $167,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,684
Previous 12,068 61.19%
Holding current value
$167,453
Previous $364,000 48.63%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $221,520 - $294,990
-7,384 Reduced 61.19%
4,684 $187,000
Q2 2024

Aug 14, 2024

SELL
$28.81 - $33.01 $470,092 - $538,624
-16,317 Reduced 57.48%
12,068 $364,000
Q1 2024

Nov 05, 2024

BUY
$29.93 - $35.06 $488,367 - $572,074
16,317 Added 135.21%
28,385 $953,000
Q1 2024

May 15, 2024

SELL
$29.93 - $35.06 $129,836 - $152,090
-4,338 Reduced 13.26%
28,385 $953,000
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $269,126 - $473,494
14,017 Added 74.93%
32,723 $1.06 Million
Q3 2023

Nov 14, 2023

BUY
$31.89 - $39.03 $219,052 - $268,097
6,869 Added 58.03%
18,706 $612,000
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $123,921 - $151,956
4,063 Added 52.26%
11,837 $416,000
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $83,314 - $145,853
-2,705 Reduced 25.81%
7,774 $253,000
Q4 2022

Feb 14, 2023

BUY
$45.4 - $60.91 $212,426 - $284,997
4,679 Added 80.67%
10,479 $577,000
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $209,584 - $276,307
4,983 Added 609.91%
5,800 $257,000
Q2 2022

Aug 15, 2022

SELL
$33.54 - $52.15 $47,794 - $74,313
-1,425 Reduced 63.56%
817 $40,000
Q1 2022

May 16, 2022

SELL
$33.14 - $51.13 $86,197 - $132,989
-2,601 Reduced 53.71%
2,242 $109,000
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $54,066 - $69,641
1,586 Added 48.7%
4,843 $206,000
Q3 2021

Nov 15, 2021

BUY
$25.68 - $38.61 $24,755 - $37,220
964 Added 42.04%
3,257 $125,000
Q2 2021

Aug 16, 2021

BUY
$25.96 - $33.44 $59,526 - $76,677
2,293 New
2,293 $65,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.12B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.